Passage BIO, Inc. EFFECT, filed Apr 14, 2022: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 14, 2022 |
| Accession Number: | 0001558370-22-002827 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||